29 results
424B5
PROK
ProKidney Corp - Ordinary Shares
13 Jun 24
Prospectus supplement for primary offering
7:00am
”) reduced disclosure obligations regarding executive compensation, and an exemption from the requirements to obtain a non-binding advisory vote … on executive compensation or golden parachute arrangements.
In addition, an emerging growth company can take advantage of an extended transition period
424B5
PROK
ProKidney Corp - Ordinary Shares
10 Jun 24
Prospectus supplement for primary offering
5:13pm
obligations regarding executive compensation, and an exemption from the requirements to obtain a non-binding advisory vote on executive compensation
DEF 14A
uq74jbr s5dkf
26 May 23
Definitive proxy
8:00am
424B3
wio8t9 21f5
21 Apr 23
Prospectus supplement
4:18pm
POS AM
5n2113 kbl5gk7867
17 Apr 23
Prospectus update (post-effective amendment)
5:01pm
424B3
vyfls ba2z
9 Sep 22
Prospectus supplement
5:05pm
8-K
byl9qxd
15 Jul 22
Revolutionary Chronic Kidney Disease Therapeutics Company ProKidney to List on the Nasdaq
5:24pm
DEFM14A
qns23
10 Jun 22
Proxy related to merger
4:54pm
8-K/A
EX-99.1
gcyo08i f3uttumlis
10 Jun 22
Other Events
4:12pm
PRER14A
y5bim1hj0ji6212er 38
11 Apr 22
Preliminary revised proxy
5:29pm
10-K
shkw078 2y0m
23 Mar 22
Annual report
5:32pm